Ligand validation:2DOR

ORO: OROTIC ACID

ORO is a Ligand Of Interest in 2DOR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2DOR_ORO_B_313	98%	4%	0.059	0.978	1.87	3.68	2	3	0	0	100%	1
2DOR_ORO_A_313	95%	5%	0.064	0.969	2.01	3.4	2	4	0	0	100%	1
1JRB_ORO_B_2313	94%	3%	0.071	0.971	2.35	3.89	4	3	0	0	100%	1
1JRC_ORO_B_2313	90%	3%	0.074	0.956	2.33	4.01	4	3	0	0	100%	1
1JQV_ORO_B_2313	60%	3%	0.126	0.911	2.53	3.51	2	2	0	0	100%	1
1OVD_ORO_B_901	51%	3%	0.148	0.903	2.72	3.17	3	3	0	0	100%	1
1JQX_ORO_B_2313	41%	3%	0.141	0.856	2.58	3.55	2	2	0	0	100%	0.8
9DHH_ORO_A_402	100%	8%	0.025	0.992	1.58	3.05	2	2	0	0	100%	1
6FMD_ORO_A_411	100%	9%	0.034	0.992	1.02	3.42	1	2	0	0	100%	1
9DHI_ORO_A_402	100%	0%	0.032	0.99	2.36	6.63	2	4	0	0	100%	1
9DHJ_ORO_A_402	100%	1%	0.033	0.989	2.35	6.35	2	4	0	0	100%	1
5H73_ORO_A_403	100%	5%	0.035	0.989	2.56	2.79	5	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.